74 related articles for article (PubMed ID: 3210623)
1. [Immunologic indices in patients with cancer of the breast following surgical treatment].
Iarygin LM; Malyshev VS; Denisov LE; Zimin IuI
Khirurgiia (Mosk); 1988 Nov; (11):42-6. PubMed ID: 3210623
[No Abstract] [Full Text] [Related]
2. Surgery-induced immunomodulation in breast cancer.
Chen XB; Fang XD; Zhang HL
J Surg Oncol; 2011 Feb; 103(2):197; author reply 196. PubMed ID: 21259258
[No Abstract] [Full Text] [Related]
3. Breast cancer surgery-induced immunomodulation.
Boomsma MF; Garssen B; Slot E; Berbee M; Berkhof J; Meezenbroek Ede J; Slieker W; Visser A; Meijer S; Beelen RH
J Surg Oncol; 2010 Nov; 102(6):640-8. PubMed ID: 20677220
[TBL] [Abstract][Full Text] [Related]
4. [The immune response during combined treatment of breast cancer].
Nechushkin MI; Veskova TK; Derevnina IA; Ukrainets AM
Med Radiol (Mosk); 1988 Sep; 33(9):45-8. PubMed ID: 3419299
[TBL] [Abstract][Full Text] [Related]
5. [Breast cancer: a dynamic approach of cellular immunity and immunostimulation with an immunoadjuvant: P40 fraction. (author's transl)].
Santus JP; Henocq E; Bizzini B; Bazin JC; Mogenet M; Villet R; Reynier J
Pathol Biol (Paris); 1979 Sep; 27(7):395-401. PubMed ID: 388318
[TBL] [Abstract][Full Text] [Related]
6. Complex immunological monitoring of breast cancer patients treated postoperatively by electron beam irradiation.
Horváth M; Horváth A; Fekete B; Tóth J
Strahlenther Onkol; 1986 May; 162(5):333-7. PubMed ID: 3520908
[TBL] [Abstract][Full Text] [Related]
7. [Cellular immunity indices in benign breast tumors].
Baisheva SA; Zhalgasbaeva GT; Kaliev IuSh; Mezinova NN
Vopr Onkol; 1980; 26(5):15-9. PubMed ID: 7385708
[TBL] [Abstract][Full Text] [Related]
8. Assessment of host immune response in breast cancer patients.
Akimoto M; Ishii H; Nakajima Y; Iwasaki H; Tan M; Abe R; Kasai M
Cancer Detect Prev; 1986; 9(3-4):311-7. PubMed ID: 3488806
[TBL] [Abstract][Full Text] [Related]
9. A biological basis for the surgical treatment of clinically curable breast cancer.
Fisher B
Bull Soc Int Chir; 1972; 31(6):604-9. PubMed ID: 4655047
[No Abstract] [Full Text] [Related]
10. [Comparison of metabolic and immunologic indices in breast cancer].
Poroshina TE; Fedorov SN; Ostroumova MN; Dil'man VM
Vopr Onkol; 1980; 26(8):24-7. PubMed ID: 7415045
[TBL] [Abstract][Full Text] [Related]
11. [Immunologic studies using the leukocyte adherence inhibition test in the diagnosis and postoperative follow-up of breast cancer].
Storch H; Granetzny A
Z Gesamte Inn Med; 1987 Jan; 42(2):41-4. PubMed ID: 3554795
[TBL] [Abstract][Full Text] [Related]
12. Comparison of the efficacy of different doses of Ukrain in the combined treatment of breast cancer.
Uglyanitsa KN; Nefyodov LI; Doroshenko YM; Brzosko WJ
Drugs Exp Clin Res; 2000; 26(5-6):201-21. PubMed ID: 11345028
[TBL] [Abstract][Full Text] [Related]
13. [Morphological manifestations of the immune response in breast cancer as indices of disorders of immune homeostasis, adequacy of treatment and evaluation of prognosis].
Dorosevich AE; Abrosimov AIu
Arkh Patol; 1987; 49(7):83-7. PubMed ID: 3310972
[TBL] [Abstract][Full Text] [Related]
14. [Circulating immune complexes and immunologic reactivity in breast cancer].
Bilynskiĭ BT; Loginskiĭ VE; Fetsich TG
Eksp Onkol; 1984; 6(3):50-2. PubMed ID: 6333978
[TBL] [Abstract][Full Text] [Related]
15. Influence of Ukrain on patients with surgically treated breast cancer. Part III. The immune system.
Fomin KA; Uglyanica KN; Nefyodov LI; Djurd TI; Nowicky JW; Brzosko WJ; Jankowski A
Drugs Exp Clin Res; 1996; 22(3-5):143-5. PubMed ID: 8899318
[TBL] [Abstract][Full Text] [Related]
16. Immune status in patients cured of breast and gynaecological cancer.
Haim N; Rudik L; Samuelly B; Mekori T; Robinson E
Clin Oncol; 1981 Jun; 7(2):141-7. PubMed ID: 7249436
[No Abstract] [Full Text] [Related]
17. Does subjective burden of early breast cancer and its treatment affect immune measures during adjuvant therapy?
Sabbioni ME; Bernhard J; Siegrist HP; Schmitz SF; Gertsch MC; Thürlimann B; Bonnefoi H; Perey L; Herrmann R; Goldhirsch A; Hürny C;
Breast Cancer Res Treat; 2004 Sep; 87(1):75-86. PubMed ID: 15377853
[TBL] [Abstract][Full Text] [Related]
18. Does adjuvant cyclophosphamide augment immune status of breast cancer patients?
Agrawal PK
Indian J Cancer; 1986 Mar; 23(1):1-4. PubMed ID: 3546096
[No Abstract] [Full Text] [Related]
19. [Quantitative morphological characteristics of the changes in the effector component of the immune system in dyshormonal hyperplasias and breast cancer].
Abrakova EL
Vopr Onkol; 1982; 28(10):81-5. PubMed ID: 7147824
[TBL] [Abstract][Full Text] [Related]
20. [Cellular immunity in breast cancer patients].
Spielmann M; Kitschke HJ; Tietje K
Onkologie; 1982 Aug; 5 Suppl():42-5. PubMed ID: 6752790
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
